For the quarter ending 2025-09-30, NUVL had -$11,718K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -122,437 | -184,235 |
| Stock-based compensation expense | 22,314 | 42,454 |
| Net accretion on marketable securities | -2,187 | -6,990 |
| Change in fair value of related party revenue share liability | -19,810 | -7,470 |
| Other non-cash | -99 | -130 |
| Prepaid expenses and other current assets | -170 | -134 |
| Other assets | 2,131 | 10,961 |
| Accounts payable | 8,668 | 8,117 |
| Accrued expenses and other liabilities | 5,232 | 12,462 |
| Net cash used in operating activities | -70,462 | -131,419 |
| Purchases of marketable securities | 178,472 | 435,251 |
| Proceeds from maturities and sales of marketable securities | 232,443 | 538,146 |
| Net cash provided by (used in) investing activities | 53,971 | 102,895 |
| Proceeds from issuance of common stock, net | 4,773 | 10,309 |
| Payments of equity issuance costs | 0 | 6 |
| Payments of insurance costs financed by a third-party | 0 | 0 |
| Net cash provided by financing activities | 4,773 | 10,303 |
| Net increase (decrease) in cash and cash equivalents | -11,718 | -18,221 |
| Cash and cash equivalents at beginning of period | 145,691 | - |
| Cash and cash equivalents at end of period | 115,752 | - |
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)